July 2025

Pharma Courses
Interview for Guest / Visiting Faculty at Guru Gobind Singh Indraprastha University
30 July 2025

Interview for Guest / Visiting Faculty at Guru Gobind Singh Indraprastha University

Pharm.D or Ph.D. those candidates who have submitted Ph.D. thesis and Viva- Voce is awaited are also eligible for the interview. qualification recognized by PCI with a B.Pharm. from an institution approved by PCI under section 12 of Pharmacy Act, 1948.
30 July 2025
NII Openings for Life Sciences, Biochemistry, Biotechnology - Salary Rs. 45,880 pm
Masters Degree in Biochemistry, Immunology, Biotechnology, Life science or related fields. NET-JRF or equivalent National-Level fellowship examination qualification is desirable
30 July 2025
Advertisement for Chemistry, Biochemistry, Analytical chemistry at TIFR
Full Time Science Graduate (from a recognized University/Institute with aggregate of 60% marks) in Chemistry/Biochemistry/Biological Chemistry/Analytical chemistry 
30 July 2025
Career for Research Scientist at PGIMER - Salary Rs. 67,200 pm
First class postgraduate degree, including the integrate PG degree. Second class postgraduate degree, including the integrated PG degrees with PhD.
30 July 2025
Sun Pharma Walk in Drive for M.Pharm, B.Pharm, MSc in QA, QC, Warehouse
3-8 years of hands-on experience with HPLC, GC, KF, IR, UV, and other analytical instruments
30 July 2025
Multiple Openings for M.Pharm, MSc, MTech at Dr. Reddy’s Laboratories
Analytical Method development, Working knowledge in HPLC/UHPLC/GC, Any experience in peptide analysis and characterization is preferred. 
30 July 2025
Opening for Quality Assurance Department at Gland Pharma - M.Pharm, B.Pharm, MSc Apply
Experience in review of HPLC, GC, LCMS calibration data & Analytical Data review &Review of Analytical Method Validations, Method Transfers, Protocols & Reports.
30 July 2025
Emcure Walk in Drive for M.Pharm, B.Pharm, MSc in Production, QC
Emcure is fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products globally.
30 July 2025
Walk in Drive for M.Pharm, B.Pharm, MSc in QA, QC at Gufic Biosciences
Experience 3 to 8 Years injectable plant IPQA, GLP, QMS, Validation, Calibration & Vendor qualification.
30 July 2025
FDA Approves Medication to Treat 2 Rare Diseases that Can Lead to Kidney Failure

The U.S. Food and Drug Administration (FDA) approved a new indication for Empaveli (pegcetacoplan) injection to treat adults and children aged 12 years and older with C3 glomerulopathy (C3G) or primary immune-complex membranoproliferative glomerulonephritis (IC-MPGN), two rare kidney diseases that can cause kidney failure. This will be the first medication approved for children with C3G and the first medication approved for the treatment of adults and children with primary IC-MPGN.